Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mucositis × Imatinib Mesylate × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 79 Leukemia 45 Gastrointestinal Stromal Tumors 37 Leukemia, Myeloid, Chronic-Phase 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Blast Crisis 14 Philadelphia Chromosome 13 Brain Neoplasms 11 Lung Neoplasms 9 Gliosarcoma 9 Glioblastoma 9 Leukemia, Myeloid, Acute 8 Sarcoma 7 Leukemia, Myeloid, Accelerated Phase 7 Glioma 7 Prostatic Neoplasms 6 Oligodendroglioma 6 Neoplasms 6 Neoplasm Metastasis 6 Dermatofibrosarcoma 6 Small Cell Lung Carcinoma 5 Melanoma 5 Central Nervous System Neoplasms 5 Astrocytoma 5 Stomach Neoplasms 4 Recurrence 4 Primary Myelofibrosis 4 Ovarian Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Myeloid 4

Interventions

Radiotherapy 5 Injections 3 Fibroblast Growth Factor 7 3 Drug Therapy 3 Xylitol 2 Water 2 Propolis 2 Mouthwashes 2 Morphine 2 Methotrexate 2 Melphalan 2 Interleukin 1 Receptor Antagonist Protein 2 Gabapentin 2 Cisplatin 2 peppermint oil 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1 cyclohexaneacetic acid 1 calcium phosphate 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 acetaminophen, hydrocodone drug combination 1 Whole-Body Irradiation 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡